Detalhe da pesquisa
1.
Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil.
AIDS Res Ther
; 19(1): 12, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35209929
2.
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil.
Ann Hepatol
; 20: 100257, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949786
3.
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
J Infect Dis
; 222(Suppl 1): S31-S40, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645160
4.
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
J Antimicrob Chemother
; 74(2): 480-488, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30376108
5.
Prevalence of HIV-1 transmitted drug resistance and viral suppression among recently diagnosed adults in São Paulo, Brazil.
Arch Virol
; 164(3): 699-706, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30569276
6.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Ann Hepatol
; 17(6): 959-968, 2018 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30600291
7.
Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.
AIDS Behav
; 21(5): 1278-1287, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27531461
8.
Barriers to access to care reported by women living with HIV across 27 countries.
AIDS Care
; 27(10): 1220-30, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168817
9.
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.
Lancet
; 382(9893): 700-8, 2013 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23830355
10.
Clinical and epidemiological features of mpox in a Brazilian reference center for HIV and sexually transmitted infections: A cross-sectional study.
IJID Reg
; 10: 114-122, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269305
11.
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1.
Infect Dis Ther
; 12(9): 2321-2335, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751019
12.
Contextualizing and optimizing novel strategies to improve the latent TB continuum of care: Insights from people living with HIV and health care providers in Brazil.
PLOS Glob Public Health
; 3(1): e0001251, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962892
13.
Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
Lancet HIV
; 10(2): e84-e96, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565708
14.
Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study.
Lancet Reg Health Am
; 28: 100642, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076411
15.
Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial.
J Infect Dis
; 201(4): 590-9, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064072
16.
Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study.
Int J STD AIDS
; 32(13): 1231-1241, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311605
17.
Possible risk compensation, attitudes, and beliefs among Brazilian individuals potentially eligible for pre-exposure prophylaxis.
Int J STD AIDS
; 32(9): 806-815, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33615909
18.
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lancet
; 374(9692): 796-806, 2009 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19647866
19.
Impact of the background regimen on virologic response to etravirine: pooled 48-week analysis of DUET-1 and -2.
HIV Clin Trials
; 11(4): 175-85, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974573
20.
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.
PLoS One
; 14(8): e0221281, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430318